Long-term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension

被引：0
|
作者：
Kimball, A. B. [1 ,2 ]
Papp, K. A. [3 ]
Wasfi, Y. [4 ]
Chan, D. [4 ]
Bissonnette, R. [5 ]
Sofen, H. [6 ]
Yeilding, N. [4 ]
Li, S. [4 ]
Szapary, P. O. [4 ]
Gordon, K. B. [7 ,8 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Prob Med Res, Waterloo, ON, Canada
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Innovaderm Res Inc, Montreal, PQ, Canada
[6] Dermatol Res Associates, Los Angeles, CA USA
[7] N Shore Univ Hlth Syst, Chicago, IL USA
[8] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2012年 / 167卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [21] Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
    Sandborn, W.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L. -L.
    Johanns, J.
    Sands, B.
    Hanauer, S. B.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. -F.
    Feagan, B. G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S6 - S6
  • [22] Long-term Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease up to 3 Years of Treatment: Results From the FORTIFY Open-Label Long-term Extension
    Ferrante, M.
    Panaccione, R.
    Colombel, J. F.
    Dubinsky, M.
    Hisamatsu, T.
    Lindsay, J. O.
    Song, A.
    Neimark, E.
    Zhang, Y.
    Kligys, K.
    Crowley, J.
    Duan, W. R.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I167 - I169
  • [23] LONG TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH 2 YEARS
    Sandborn, W. J.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L.
    Johanns, J.
    Sands, B.
    Hanauer, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. F.
    Feagan, B. G.
    GUT, 2017, 66 : A22 - A22
  • [24] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results From the UNIFI Long-Term Extension
    Sands, Bruce E.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S525 - S526
  • [25] Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
    Rostaing, L.
    Vincenti, F.
    Grinyo, J.
    Rice, K. M.
    Bresnahan, B.
    Steinberg, S.
    Gang, S.
    Gaite, L. E.
    Moal, M-C
    Mondragon-Ramirez, G. A.
    Kothari, J.
    Pupim, L.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2875 - 2883
  • [26] Long-term safety of ustekinumab: Five years of follow-up from the psoriasis clinical development program including patients with psoriatic arthritis
    Papp, K.
    Griffiths, C. E. M.
    Gordon, K.
    Lebwohl, M.
    Szapary, P. O.
    Wasfi, Y.
    Chan, D.
    Shen, Y. K.
    Ho, V.
    Ghislain, P. D.
    Strober, B.
    Reich, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 30 - 30
  • [27] Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study
    Mahe, Emmanuel
    Geldhof, Anja
    Movshovich, Evgenia
    Schreiber, Joerg
    Malynn, Sandra
    Efficace, Michela
    Seyger, Marieke M. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) : E43 - E43
  • [28] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, M. T.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Tikhonov, I.
    Zhang, H.
    Panacciones, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R. W.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Afif, W.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S113 - S114
  • [29] Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience
    Conti, Andrea
    Galdo, Giovanna
    Greco, Maurizio
    Borsari, Stefania
    Lasagni, Claudia
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S84 - S86
  • [30] LONG-TERM FOLLOW-UP OF PATIENTS RECEIVING APRINDINE - SAFETY AND EFFICACY
    STRASBERG, B
    PRECHEL, D
    BAUMAN, J
    COELHO, A
    SWIRYN, S
    BAUERNFEIND, R
    ROSEN, KM
    ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (11) : 2131 - 2133
12345